Fever + Lower Body Pain: Clinical Overview

What Is Happening Physiologically

• Rosen's Emergency Medicine, p.124

Most Likely Causes (Differential Diagnosis)

1. Viral Infections (most common overall)

• Sudden high-grade fever, frontal headache, retroorbital pain, back pain, and severe myalgia - the hallmarks
• Transient macular rash, conjunctival redness, lymphadenopathy
• Lab: leukopenia, thrombocytopenia
• Lasts 7-10 days; watch for warning signs (abdominal pain, vomiting, bleeding) around day 3-5
• Harrison's Principles of Internal Medicine 22E, ch. on Fever & Myalgia

• Abrupt onset fever, prominent myalgia, headache, and fatigue with or without respiratory symptoms
• Common in all regions; rapid flu test available

• Zika: low-grade fever, itchy maculopapular rash, arthralgia/myalgia, non-purulent conjunctivitis
• Chikungunya: high fever, severe joint pain in lower limbs

• Can present with fever, myalgia, body aches, fatigue - respiratory symptoms may or may not be prominent

2. Urinary Tract / Kidney Infection

• Fever + lower back/flank pain (often unilateral) = classic pyelonephritis (kidney infection)
• May have burning urination, frequency, or cloudy urine
• Common especially in women; requires antibiotics (not self-limiting)

3. Malaria

• Cyclical or persistent high fever, chills, severe myalgia, headache
• Must consider in anyone in or returning from a malaria-endemic area
• Requires urgent blood smear / RDT testing - can be life-threatening

4. Typhoid Fever

• Gradually rising fever over days, back pain, body aches, anorexia, constipation or diarrhea
• Relative bradycardia, "rose spots" rash (rare)
• Common in areas with contaminated water

5. Leptospirosis

• Sudden fever, chills, headache, intense myalgia especially in the calves, back, and abdomen, conjunctival suffusion
• Linked to exposure to water/soil contaminated with animal urine
• Harrison's, discussing leptospirosis: "Muscle pain is intense and especially affects the calves, back, and abdomen"

6. Musculoskeletal / Other

• Post-exercise soreness + coincidental viral illness
• Spinal epidural abscess (rare but serious if persistent back pain + fever + neurological symptoms)

Red Flag Symptoms - Seek Emergency Care Immediately

Basic Assessment

• Location of body pain (calves? back? joints? all over?)
• Any rash, red eyes, sore throat, cough, runny nose?
• Urinary symptoms (burning, frequency)?
• Recent travel to tropical areas?
• Exposure to mosquitoes, contaminated water?
• Any bleeding (gums, nose, under skin)?

• Complete blood count (CBC) - leukocytosis suggests bacterial; leukopenia + thrombocytopenia suggests dengue
• Peripheral blood smear / malaria RDT (if endemic area)
• Urine routine/microscopy (rule out UTI/pyelonephritis)
• Dengue NS1 antigen / IgM (days 1-5 of illness)
• Typhoid: Widal test or blood culture

General Management (While Awaiting Diagnosis)

• Paracetamol (acetaminophen) 500-1000 mg every 6-8 hours for fever and pain - preferred over NSAIDs/ibuprofen until dengue is ruled out (NSAIDs increase bleeding risk in dengue)
• Adequate oral hydration - fever increases fluid loss
• Rest
• Monitor temperature chart (pattern helps diagnosis)
• Do not use aspirin in children (Reye's syndrome risk)

Bottom Line

Disclaimer: This information is for educational purposes. Please consult a qualified healthcare professional for personal medical advice, diagnosis, or treatment.

Latest Dengue & Malaria Guidelines (International, 2024-2025)

DENGUE

Landmark Update: WHO Arboviral Disease Guidelines - July 2025

• Over 4 million dengue cases and 3,000+ deaths reported Jan-July 2025 from 97 countries
• 2024 saw 14.4 million cases worldwide - unprecedented levels
• Dengue is now spreading to Europe (France, Italy, Spain) and the Eastern Mediterranean

• No specific antiviral exists for dengue
• Paracetamol (acetaminophen) - preferred antipyretic and analgesic
• Avoid NSAIDs and aspirin - increase bleeding risk
• Oral hydration for uncomplicated dengue; IV fluids for dengue with warning signs
• Hospitalize if warning signs present
• Platelet transfusion only if severe thrombocytopenia with active bleeding (not prophylactically)
• The CDC Dengue Clinical Management Pocket Guide (updated May 2024) provides bedside algorithms by patient group

• Days 1-5 (febrile phase): NS1 antigen ELISA or RT-PCR
• Day 5 onwards: IgM/IgG serology
• Always check CBC - thrombocytopenia + leukopenia strongly suggest dengue

MALARIA

WHO Guidelines for Malaria - Living Document, Updated August 2025

• Parasitological confirmation with microscopy or rapid diagnostic test (RDT) is required before starting antimalarials
• Treatment based on clinical grounds only if testing unavailable within 2 hours of presentation
• Treat within 24 hours of fever onset to prevent severe disease

• Artemisinin-based combination therapies (ACTs) remain the backbone of treatment worldwide
• Approved first-line ACTs include:
  • Artemether-lumefantrine (AL) - most widely used globally
  • Artesunate-amodiaquine (ASAQ)
  • Dihydroartemisinin-piperaquine (DHP)
  • Artesunate-mefloquine
  • Pyronaridine-artesunate (newer option, Cochrane review 2025, PMID: 41085194 confirms efficacy)
• A Nov 2024 WHO policy now recommends multiple first-line therapies (MFT) to combat artemisinin resistance

• IV/IM artesunate is the drug of choice (preferred over quinine)
• Pre-referral: rectal artesunate for children who cannot receive IV therapy

• Pregnant women (1st trimester): quinine + clindamycin (artemisinin safety under review; WHO safety report, April 2024)
• Children: weight-based dosing of ACTs; rectal artesunate for pre-referral in severe malaria

• Artemisinin partial resistance emerging in sub-Saharan Africa (especially East Africa) - a 2025 meta-analysis (PMID: 41291512) confirmed ACT efficacy remains >90% across sub-Saharan Africa through 2024, but rising resistance is being monitored closely

• 263 million cases and 597,000 deaths in 2023 - World Malaria Report 2024
• ~95% of deaths in WHO African Region
• RTS,S/AS01 malaria vaccine now being rolled out in several African countries (e.g., Burundi in 2025)

Quick Reference: Dengue vs. Malaria Management

Note: Regional guidelines (India, Southeast Asia, Africa, Latin America) may specify preferred ACTs based on local resistance patterns. Always consult your national health ministry's malaria treatment protocol, which is typically adapted from WHO guidelines.